David J. Braun

1.1k total citations
22 papers, 837 citations indexed

About

David J. Braun is a scholar working on Neurology, Physiology and Molecular Biology. According to data from OpenAlex, David J. Braun has authored 22 papers receiving a total of 837 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Neurology, 7 papers in Physiology and 4 papers in Molecular Biology. Recurrent topics in David J. Braun's work include Neuroinflammation and Neurodegeneration Mechanisms (9 papers), Alzheimer's disease research and treatments (6 papers) and Animal Ecology and Behavior Studies (2 papers). David J. Braun is often cited by papers focused on Neuroinflammation and Neurodegeneration Mechanisms (9 papers), Alzheimer's disease research and treatments (6 papers) and Animal Ecology and Behavior Studies (2 papers). David J. Braun collaborates with scholars based in United States, Spain and Italy. David J. Braun's co-authors include Douglas L. Feinstein, Sergey Kalinin, Linda J. Van Eldik, Claudia Späni, Annunziato Mangiola, Cinzia Dello Russo, Carmelo Anile, Lucia Lisi, Pierluigi Navarra and Gabriella Maria Pia Ciotti and has published in prestigious journals such as PLoS ONE, Brain Research and Biophysical Journal.

In The Last Decade

David J. Braun

22 papers receiving 831 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David J. Braun United States 15 223 205 163 139 137 22 837
Alejandro Villarreal Argentina 16 286 1.3× 348 1.7× 151 0.9× 109 0.8× 159 1.2× 27 969
Shongshan Fan United States 20 345 1.5× 522 2.5× 120 0.7× 198 1.4× 264 1.9× 26 1.4k
Long Wang China 20 88 0.4× 393 1.9× 113 0.7× 90 0.6× 102 0.7× 74 1.0k
Leonardo Cavone Italy 22 189 0.8× 580 2.8× 163 1.0× 186 1.3× 201 1.5× 31 1.3k
Xiaosheng He China 18 180 0.8× 674 3.3× 103 0.6× 115 0.8× 163 1.2× 41 1.2k
Filipa L. Cardoso Portugal 12 498 2.2× 380 1.9× 125 0.8× 64 0.5× 115 0.8× 13 1.1k
Katherine Jackman Australia 16 345 1.5× 350 1.7× 195 1.2× 187 1.3× 96 0.7× 23 1.1k
Mei Yuanwu China 19 243 1.1× 300 1.5× 71 0.4× 86 0.6× 118 0.9× 41 867

Countries citing papers authored by David J. Braun

Since Specialization
Citations

This map shows the geographic impact of David J. Braun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David J. Braun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David J. Braun more than expected).

Fields of papers citing papers by David J. Braun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David J. Braun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David J. Braun. The network helps show where David J. Braun may publish in the future.

Co-authorship network of co-authors of David J. Braun

This figure shows the co-authorship network connecting the top 25 collaborators of David J. Braun. A scholar is included among the top collaborators of David J. Braun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David J. Braun. David J. Braun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Braun, David J., Christopher J. McLouth, David K. Powell, et al.. (2024). A small molecule p38α MAPK inhibitor, MW150, attenuates behavioral deficits and neuronal dysfunction in a mouse model of mixed amyloid and vascular pathologies. Brain Behavior & Immunity - Health. 40. 100826–100826. 5 indexed citations
2.
3.
Braun, David J., et al.. (2022). Exogenous Short Chain Fatty Acid Effects in APP/PS1 Mice. Frontiers in Neuroscience. 16. 873549–873549. 13 indexed citations
5.
Braun, David J., Edgardo Dimayuga, Josh M. Morganti, & Linda J. Van Eldik. (2020). Microglial-associated responses to comorbid amyloid pathology and hyperhomocysteinemia in an aged knock-in mouse model of Alzheimer’s disease. Journal of Neuroinflammation. 17(1). 274–274. 14 indexed citations
6.
Macheda, Teresa, Kelly N. Roberts, Josh M. Morganti, David J. Braun, & Adam D. Bachstetter. (2020). Optimization and validation of a modified radial-arm water maze protocol using a murine model of mild closed head traumatic brain injury. PLoS ONE. 15(8). e0232862–e0232862. 12 indexed citations
7.
Braun, David J., Adam D. Bachstetter, Tiffany L. Sudduth, et al.. (2019). Genetic knockout of myosin light chain kinase (MLCK210) prevents cerebral microhemorrhages and attenuates neuroinflammation in a mouse model of vascular cognitive impairment and dementia. GeroScience. 41(5). 671–679. 14 indexed citations
8.
Braun, David J. & Linda J. Van Eldik. (2018). In vivo Brainstem Imaging in Alzheimer’s Disease: Potential for Biomarker Development. Frontiers in Aging Neuroscience. 10. 266–266. 12 indexed citations
9.
Späni, Claudia, David J. Braun, & Linda J. Van Eldik. (2018). Sex-related responses after traumatic brain injury: Considerations for preclinical modeling. Frontiers in Neuroendocrinology. 50. 52–66. 128 indexed citations
10.
Lisi, Lucia, Gabriella Maria Pia Ciotti, David J. Braun, et al.. (2017). Expression of iNOS, CD163 and ARG-1 taken as M1 and M2 markers of microglial polarization in human glioblastoma and the surrounding normal parenchyma. Neuroscience Letters. 645. 106–112. 190 indexed citations
11.
Braun, David J. & Douglas L. Feinstein. (2017). The locus coeruleus neuroprotective drug vindeburnol normalizes behavior in the 5xFAD transgenic mouse model of Alzheimer’s disease. Brain Research. 1702. 29–37. 28 indexed citations
12.
Braun, David J., Sergey Kalinin, & Douglas L. Feinstein. (2017). Conditional Depletion of Hippocampal Brain-Derived Neurotrophic Factor Exacerbates Neuropathology in a Mouse Model of Alzheimer’s Disease. ASN NEURO. 9(2). 1662273441–1662273441. 26 indexed citations
13.
Martynowycz, Michael W., Ivan Kuzmenko, David J. Braun, et al.. (2016). Membrane Cholesterol Modulates Superwarfarin Toxicity. Biophysical Journal. 110(8). 1777–1788. 16 indexed citations
14.
Feinstein, Douglas L., Belinda S. Akpa, Anne I. Boullerne, et al.. (2016). The emerging threat of superwarfarins: history, detection, mechanisms, and countermeasures. Annals of the New York Academy of Sciences. 1374(1). 111–122. 50 indexed citations
15.
Braun, David J., Ana Lis Moyano, Sergey Kalinin, et al.. (2016). Differential effects on glial activation by a direct versus an indirect thrombin inhibitor. Journal of Neuroimmunology. 297. 159–168. 17 indexed citations
16.
Boullerne, Anne I., Paul Polak, David J. Braun, et al.. (2014). Effects of peptide fraction and counter ion on the development of clinical signs in experimental autoimmune encephalomyelitis. Journal of Neurochemistry. 129(4). 696–703. 14 indexed citations
17.
Braun, David J., José L. M. Madrigal, & Douglas L. Feinstein. (2014). Noradrenergic Regulation of Glial Activation: Molecular Mechanisms and Therapeutic Implications. Current Neuropharmacology. 12(4). 342–352. 47 indexed citations
18.
Glick, Roberta P., et al.. (2013). Beneficial actions of the anti-inflammatory dimethyl fumarate in glioblastomas. Surgical Neurology International. 4(1). 160–160. 27 indexed citations
19.
Kalinin, Sergey, Paul Polak, Shao Xia Lin, et al.. (2013). Dimethyl fumarate regulates histone deacetylase expression in astrocytes. Journal of Neuroimmunology. 263(1-2). 13–19. 40 indexed citations
20.
Polak, Paul, Sergey Kalinin, David J. Braun, et al.. (2012). The vincamine derivative vindeburnol provides benefit in a mouse model of multiple sclerosis: effects on the Locus coeruleus. Journal of Neurochemistry. 121(2). 206–216. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026